Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
32.59
-0.39 (-1.18%)
At close: Nov 20, 2026, 4:00 PM EST
32.43
-0.16 (-0.49%)
After-hours: Nov 20, 2026, 7:30 PM EST
HRMY Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, HRMY stock has a consensus rating of "Buy" and an average price target of $48.08. The average 1-year stock price forecast is 47.53% higher than the current stock price, while the lowest is $32 (-1.81%) and the highest is $70 (+114.79%).
Price Target: $48.08 (+47.53%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HRMY stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 → $55 | Buy | Reiterates | $20 → $55 | +68.76% | Nov 18, 2026 |
| UBS No rating | UBS | Hold Maintains $37 → $39 | Hold | Maintains | $37 → $39 | +19.67% | Nov 6, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $51 → $49 | Buy | Maintains | $51 → $49 | +50.35% | Oct 29, 2026 |
| Needham | Needham | Buy Reiterates $50 | Buy | Reiterates | $50 | +53.42% | Oct 19, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $55 | Buy | Initiates | $55 | +68.76% | Oct 15, 2026 |
Financial Forecast
Revenue This Year
1.03B
from 868.45M
Increased by 18.31%
Revenue Next Year
1.18B
from 1.03B
Increased by 14.97%
EPS This Year
4.76
from 3.60
Increased by 32.27%
EPS Next Year
6.06
from 4.76
Increased by 27.34%
EPS and Forward PE are based on non-GAAP adjusted numbers.